A Post-marketing Safety Study of Beijing Tiantan Biological's Influenza Virus Vaccine in Elderly

Clinical trial NCT01906593 · COMPLETED

Trial details

NCT number: NCT01906593
Sponsor: Centers for Disease Control and Prevention, China
Status: COMPLETED
Study type: OBSERVATIONAL

Influenza Vaccination Adverse Event

Start date: 2013-06-01
Primary completion: 2013-07-01
Enrollment: 536812

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.